William B. Walkup & Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.8K Sell
4,570
-46
-1% -$1.05K 0.05% 98
2026
Q1
$62.5K Buy
4,616
+3
+0.1% +$52 0.04% 98
2025
Q4
$54.4K Hold
4,613
0.03% 101
2025
Q3
$73.1K Sell
4,613
-3
-0.1% -$44 0.04% 94
2025
Q2
$52.9K Hold
4,616
0.03% 98
2025
Q1
$62.5K Hold
4,616
0.04% 97
2024
Q4
$78K Hold
4,616
0.05% 97
2024
Q3
$93.8K Sell
4,616
-123
-3% -$2.51K 0.06% 94
2024
Q2
$107K Buy
+4,739
New +$124K 0.07% 91

Other funds holding CC

William B. Walkup & Associates's CC Position: Q2 2026 in Review

William B. Walkup & Associates reduced its Chemours (CC) stake by 1% in Q2 2026, selling an estimated $1.05K and leaving 4,570 shares worth $93.8K. The position accounts for 0.05% of the portfolio, ranked #98.

William B. Walkup & Associates first reported a position in CC in Q2 2024 and has held it in 9 quarters since. The position peaked at $107K in Q2 2024. 157 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • William B. Walkup & Associates held 4,570 shares of Chemours worth $93.8K as of Q2 2026.
  • William B. Walkup & Associates sold 46 Chemours shares in Q2 2026, an estimated $1.05K.
  • Chemours made up 0.05% of William B. Walkup & Associates's portfolio in Q2 2026, its #98 holding.
  • William B. Walkup & Associates first reported a position in Chemours in Q2 2024 and has held it in 9 quarters since.
  • William B. Walkup & Associates's Chemours position peaked at $107K in Q2 2024.
  • 157 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.